Page last updated: 2024-08-02 05:46:09
rwj-333369
Description
S-2-O-carbamoyl-1-o-chlorophenyl-ethanol: neuromodulator/Antiepileptic Agent; structure in first source [MeSH]
carisbamate : no description available [CHeBI]
Cross-References
Synonyms (39)
Synonym |
jnj-10234094 |
ykp-509 |
comfyde |
rwj-333369 |
carisbamate |
D06573 |
carisbamate (usan) |
194085-75-1 |
CHEBI:135966 |
[(2s)-2-(2-chlorophenyl)-2-hydroxyethyl] carbamate |
rwj 333369 |
s-2-o-carbamoyl-1-o-chlorophenyl-ethanol |
(+)-(2s)-2-(2-chlorophenyl)-2-hydroxyethyl carbamate |
unii-p7725i9v3z |
carisbamate [usan:inn] |
1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (1s)- |
p7725i9v3z , |
1,2-ethanediol,1-(2-chlorophenyl)-, 2-carbamate, (1s)- |
rwj-333369-000 |
CHEMBL2087003 |
SCHEMBL729003 |
(2s)-2-(2-chlorophenyl)-2-hydroxyethyl carbamate |
carisbamate [who-dd] |
carisbamate [mi] |
carisbamate [usan] |
(s)-2-o-carbamoyl-1-o-chlorophenyl-ethanol |
carisbamate [inn] |
(s)-2-carbamoyloxy-1-o-chlorophenylethanol |
OLBWFRRUHYQABZ-MRVPVSSYSA-N |
(s)-carisbamate |
DTXSID70426076 |
DB12338 |
EX-A7280 |
rwj 333369; ykp 509 |
(s)-2-(2-chlorophenyl)-2-hydroxyethyl carbamate |
EN300-8659675 |
CS-0003652 |
HY-14948 |
AKOS040751033 |
Drug Classes (1)
Class | Description |
organochlorine compound | An organochlorine compound is a compound containing at least one carbon-chlorine bond. |
Bioassays (5)
Assay ID | Title | Year | Journal | Article |
AID684345 | Anticonvulsant activity in po dosed Sprague-Dawley albino rat assessed as protection against subcutaneous metrazol-induced seizures | 2012 | Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6 ISSN: 1520-4804 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. |
AID684127 | Neurotoxicity in po dosed Sprague-Dawley albino rat assessed as minimal motor impairment by rotarod test | 2012 | Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6 ISSN: 1520-4804 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. |
AID684339 | Anticonvulsant activity in po dosed Sprague-Dawley albino rat assessed as protection against maximal electroshock-induced seizures | 2012 | Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6 ISSN: 1520-4804 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. |
AID684348 | Protective index, ratio of TD50 for po dosed Sprague-Dawley albino rat by rotarod test to ED50 for po dosed Sprague-Dawley albino rat by subcutaneous metrazol seizures test | 2012 | Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6 ISSN: 1520-4804 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. |
AID684342 | Protective index, ratio of TD50 for po dosed Sprague-Dawley albino rat by rotarod test to ED50 for po dosed Sprague-Dawley albino rat by maximal electroshock seizures test | 2012 | Journal of medicinal chemistry, Mar-22, Volume: 55, Issue:6 ISSN: 1520-4804 | Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates. |
Research
Studies (42)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 21 (50.00) | 29.6817 |
2010's | 19 (45.24) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 12 (27.27%) | 5.53% |
Reviews | 6 (13.64%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 26 (59.09%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
chloroacetaldehyde | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloroalanine | | chloroalanine; non-proteinogenic alpha-amino acid; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinacrine | | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlordecone | | cyclic ketone; organochlorine compound | insecticide; persistent organic pollutant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2,4-dichlorophenoxy)butyric acid | | aromatic ether; monocarboxylic acid; organochlorine compound | agrochemical; phenoxy herbicide; synthetic auxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxysaclofen | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dichloroisocoumarin | | isocoumarins; organochlorine compound | geroprotector; serine protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(n,n-hexamethylene)amiloride | | aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines | antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethylisopropylamiloride | | aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound | anti-arrhythmia drug; neuroprotective agent; sodium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-chlorokynurenic acid | | organochlorine compound; quinolinemonocarboxylic acid | neuroprotective agent; NMDA receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetochlor | | aromatic amide; monocarboxylic acid amide; organochlorine compound | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alachlor | | aromatic amide; monocarboxylic acid amide; organochlorine compound | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alprazolam | | organochlorine compound; triazolobenzodiazepine | anticonvulsant; anxiolytic drug; GABA agonist; muscle relaxant; sedative; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amodiaquine | | aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzylhydrochlorothiazide | | benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carmustine | | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carprofen | | carbazoles; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; photosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cgs 15943 | | aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline | adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloral hydrate | | aldehyde hydrate; ethanediol; organochlorine compound | general anaesthetic; mouse metabolite; sedative; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorambucil | | aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloroquine | | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloroxine | | monohydroxyquinoline; organochlorine compound | antibacterial agent; antifungal drug; antiseborrheic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorpromazine | | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorzoxazone | | 1,3-benzoxazoles; heteroaryl hydroxy compound; organochlorine compound | muscle relaxant; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ciprofibrate | | cyclopropanes; monocarboxylic acid; organochlorine compound | antilipemic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clioquinol | | monohydroxyquinoline; organochlorine compound; organoiodine compound | antibacterial agent; antifungal agent; antimicrobial agent; antineoplastic agent; antiprotozoal drug; chelator; copper chelator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clobazam | | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clobenpropit | | imidazoles; imidothiocarbamic ester; organochlorine compound | H3-receptor antagonist; H4-receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cloxyquin | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coumaphos | | organic thiophosphate; organochlorine compound; organothiophosphate insecticide | acaricide; agrochemical; antinematodal drug; avicide; EC 3.1.1.8 (cholinesterase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cypermethrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound | agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nordazepam | | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diazepam | | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diazoxide | | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enflurane | | ether; organochlorine compound; organofluorine compound | anaesthetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fludiazepam | | 1,4-benzodiazepinone; organochlorine compound; organofluorine compound | anxiolytic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flurazepam | | 1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; tertiary amino compound | anticonvulsant; anxiolytic drug; GABAA receptor agonist; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glafenine | | aminoquinoline; carboxylic ester; glycol; organochlorine compound; secondary amino compound | inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
halothane | | haloalkane; organobromine compound; organochlorine compound; organofluorine compound | inhalation anaesthetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrochlorothiazide | | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxychloroquine | | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indapamide | | indoles; organochlorine compound; sulfonamide | antihypertensive agent; diuretic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lomustine | | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
loratadine | | benzocycloheptapyridine; ethyl ester; N-acylpiperidine; organochlorine compound; tertiary carboxamide | anti-allergic agent; cholinergic antagonist; geroprotector; H1-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | | chromones; morpholines; organochlorine compound | autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mechlorethamine | | nitrogen mustard; organochlorine compound | alkylating agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meclofenamic acid | | aminobenzoic acid; organochlorine compound; secondary amino compound | analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methoxyflurane | | ether; organochlorine compound; organofluorine compound | hepatotoxic agent; inhalation anaesthetic; nephrotoxic agent; non-narcotic analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metolachlor | | aromatic amide; benzenes; ether; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metolazone | | organochlorine compound; quinazolines; sulfonamide | antihypertensive agent; diuretic; ion transport inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
midazolam | | imidazobenzodiazepine; monofluorobenzenes; organochlorine compound | anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mosapramine | | azaspiro compound; dibenzoazepine; organochlorine compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naled | | dialkyl phosphate; organobromine compound; organochlorine compound; organophosphate insecticide | acaricide; agrochemical; antibacterial agent; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxazepam | | 1,4-benzodiazepinone; organochlorine compound | anxiolytic drug; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perphenazine | | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines | antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prochlorperazine | | N-alkylpiperazine; N-methylpiperazine; organochlorine compound; phenothiazines | alpha-adrenergic antagonist; antiemetic; cholinergic antagonist; dopamine receptor D2 antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propachlor | | anilide; monocarboxylic acid amide; organochlorine compound | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol | | benzazepine; organochlorine compound; tertiary amino compound | dopaminergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
semustine | | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent; carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sibutramine | | organochlorine compound; tertiary amino compound | anti-obesity agent; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tulobuterol | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pirinixic acid | | aryl sulfide; organochlorine compound; pyrimidines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichlorfon | | organic phosphonate; organochlorine compound; phosphonic ester | agrochemical; anthelminthic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloramphenicol | | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorquinaldol | | monohydroxyquinoline; organochlorine compound | antibacterial drug; antiprotozoal drug; antiseptic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,1-dichloroethane | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichloroacetaldehyde | | aldehyde; organochlorine compound | mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichloroacetic acid | | monocarboxylic acid; organochlorine compound | carcinogenic agent; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloropicrin | | C-nitro compound; one-carbon compound; organochlorine compound | antifungal agrochemical; fumigant insecticide; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloropentafluoroethane | | organochlorine compound; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichloroacetaldehyde | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichloroacetic acid | | monocarboxylic acid; organochlorine compound | astringent; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfachlorpyridazine | | organochlorine compound; pyridazines; sulfonamide | antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiopropazate | | acetate ester; N-alkylpiperazine; organochlorine compound; phenothiazines | dopaminergic antagonist; phenothiazine antipsychotic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexachlorobutadiene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
symclosene | | 1,3,5-triazinanes; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3'-dichlorobenzidine | | biphenyls; monochlorobenzenes; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-dibromo-3-chloropropane | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2,3-trichloropropane | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dichloro-2-propanol | | organochlorine compound; secondary alcohol | cross-linking reagent; protic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzotrichloride | | benzenes; organochlorine compound; volatile organic compound | carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epichlorohydrin | | epoxide; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-bromo-2-chloroethane | | haloalkane; organobromine compound; organochlorine compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allyl chloride | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyanuric chloride | | chloro-1,3,5-triazine; organochlorine compound | cross-linking reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorendic acid | | bridged compound; dicarboxylic acid; organochlorine compound | carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tris(chloroethyl)phosphate | | organochlorine compound; trialkyl phosphate | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloranil | | 1,4-benzoquinones; organochlorine compound | EC 2.7.1.33 (pantothenate kinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
captan | | isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
folpet | | organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichloronate | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromochlorodifluoromethane | | one-carbon compound; organobromine compound; organochlorine compound; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metofenazate | | N-alkylpiperazine; organochlorine compound; phenothiazines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mustard gas | | ethyl sulfide; organochlorine compound | alkylating agent; carcinogenic agent; vesicant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-chloro-2-methylpropene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-chlorotheophylline | | organochlorine compound; purines | central nervous system stimulant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dichloroacetone | | ketone; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bis(chloromethyl) ether | | ether; organochlorine compound | alkylating agent; carcinogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichloroacetonitrile | | aliphatic nitrile; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-2-methylprop-1-ene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-dichlorobenzoquinone | | 1,4-benzoquinones; organochlorine compound | carcinogenic agent; poison | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-dichlorofluoromethylthio-n',n'-dimethyl-n-p-tolylsulfamide | | organochlorine compound; organofluorine compound; phenylsulfamide fungicide; sulfamides | antifungal agrochemical; genotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lormetazepam | | 1,4-benzodiazepinone; organochlorine compound | sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-1,4-naphthoquinone | | 1,4-naphthoquinones; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlordecone alcohol | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichlofluanid | | organochlorine compound; organofluorine compound; phenylsulfamide fungicide; sulfamides | acaricide; antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
win 18446 | | organochlorine compound; secondary carboxamide | EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrazon | | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromocyclen | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chlorouracil | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amiloride | | aromatic amine; guanidines; organochlorine compound; pyrazines | diuretic; sodium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dienochlor | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
captafol | | isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etridiazol | | aromatic ether; organochlorine compound; thiadiazole antifungal agent; thiadiazoles | antifungal agrochemical; nitrification inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-chlorobenzylidenemalonitrile | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diloxanide furoate | | carboxylic ester; furans; organochlorine compound; tertiary carboxamide | antiamoebic agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cladribine | | organochlorine compound; purine 2'-deoxyribonucleoside | antineoplastic agent; immunosuppressive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichloroacetylene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloroethylene oxide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-7-nitrobenzofurazan | | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodronic acid | | 1,1-bis(phosphonic acid); one-carbon compound; organochlorine compound | antineoplastic agent; bone density conservation agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ornidazole | | C-nitro compound; imidazoles; organochlorine compound; secondary alcohol | antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acridine half-mustard | | aminoacridines; aromatic ether; organochlorine compound; secondary amino compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
didesethylflurazepam | | 1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; primary amino compound | anticonvulsant; anxiolytic drug; drug metabolite; GABAA receptor agonist; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clonixin | | aminopyridine; organochlorine compound; pyridinemonocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorodibromomethane | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-chloro-2-propanol | | organochlorine compound; secondary alcohol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butachlor | | aromatic amide; organochlorine compound; tertiary carboxamide | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyoluteorin | | aromatic ketone; beta-hydroxy ketone; diol; organochlorine compound; organochlorine pesticide; polyketide; pyrroles; resorcinols | antibacterial agent; antifungal agent; apoptosis inducer; bacterial metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-2-methyl-4-isothiazolin-3-one | | 1,2-thiazoles; organochlorine compound | antimicrobial agent; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triforine | | amide fungicide; formamides; N-alkylpiperazine; organochlorine compound | allergen; antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxamethacin | | aromatic ether; hydroxamic acid; N-acylindole; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norflurazone | | (trifluoromethyl)benzenes; organochlorine compound; pyridazinone; secondary amino compound | agrochemical; carotenoid biosynthesis inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octachlorostyrene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perfosfamide | | nitrogen mustard; organochlorine compound; peroxol; phosphorodiamide | alkylating agent; antineoplastic agent; drug allergen; immunosuppressive agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimustine | | aminopyrimidine; N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiamenidine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acifluorfen | | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metazachlor | | aromatic amide; organochlorine compound; pyrazoles | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid | | aminopyridine; aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
haloxyfop | | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quizalofop-ethyl | | aromatic ether; ethyl ester; organochlorine compound; quinoxaline derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cicletanine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lonapalene | | naphthalenes; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sertindole | | heteroarylpiperidine; imidazolidinone; organochlorine compound; organofluorine compound; phenylindole | alpha-adrenergic antagonist; H1-receptor antagonist; second generation antipsychotic; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ziprasidone | | 1,2-benzisothiazole; indolones; organochlorine compound; piperazines | antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiludronic acid | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
r 29148 | | organochlorine compound; oxazolidines; tertiary carboxamide | herbicide safener | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
heptenophos | | organochlorine compound; organophosphate insecticide; trialkyl phosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
efavirenz | | acetylenic compound; benzoxazine; cyclopropanes; organochlorine compound; organofluorine compound | antiviral drug; HIV-1 reverse transcriptase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 5-3335 | | 1,4-benzodiazepinone; organochlorine compound; pyrroles | anti-HIV-1 agent; antineoplastic agent; HIV-1 Tat inhibitor; RUNX1 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-4-chloro-3-indolyl beta-galactoside | | beta-D-galactoside; D-aldohexose derivative; indolyl carbohydrate; organobromine compound; organochlorine compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-bromo-4-chloro-3-indoxyl phosphate | | aryl phosphate; indoles; organobromine compound; organochlorine compound | chromogenic compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
z 424 | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tianeptine | | dibenzothiazepine; monocarboxylic acid; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichlorosucrose | | disaccharide derivative; organochlorine compound | environmental contaminant; sweetening agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clobuzarit | | biphenyls; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eberconazole | | dibenzannulene; imidazoles; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gr 117289 | | 1-benzofurans; biaryl; imidazolyl carboxylic acid; monocarboxylic acid; organobromine compound; organochlorine compound; tetrazoles | angiotensin receptor antagonist; antihypertensive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rebeccamycin | | indolocarbazole; N-glycosyl compound; organic heterohexacyclic compound; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triasulfuron | | 1,3,5-triazines; aromatic ether; N-sulfonylurea; organochlorine compound | agrochemical; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5,6,7-tetrachloro-2-trifluoromethylbenzimidazole | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-((4-chlorophenyl)thio)cyclic-3',5'-amp | | 3',5'-cyclic purine nucleotide; adenyl ribonucleotide; aryl sulfide; organochlorine compound | protein kinase agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
raiser | | (trifluoromethyl)benzenes; organochlorine compound; pyrrolidines | agrochemical; carotenoid biosynthesis inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kathon 930 | | 1,2-thiazoles; organochlorine compound | environmental contaminant; fungicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinclorac | | monocarboxylic acid; organochlorine compound; quinolinemonocarboxylic acid | agrochemical; herbicide; synthetic auxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethenamid | | aromatic amide; ether; organochlorine compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluxofenim | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodinafop-propargyl | | aromatic ether; carboxylic ester; organochlorine compound; organofluorine compound; propyzamide; pyridines | agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chlorolactate | | 2-hydroxy monocarboxylic acid; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cloquintocet-mexyl | | aromatic ether; carboxylic ester; organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-dichloroisonicotinic acid | | monocarboxylic acid; organochlorine compound; pyridines | EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sporidesmin | | aromatic ether; cyclic ketone; diketone; organic disulfide; organic heteropentacyclic compound; organochlorine compound; secondary alcohol; tertiary alcohol; tertiary amino compound | mycotoxin; Wnt signalling activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxycyclophosphamide | | nitrogen mustard; organochlorine compound; phosphorodiamide | alkylating agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fotemustine | | N-nitrosoureas; organic phosphonate; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyfluthrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiamethoxam | | 1,3-thiazoles; 2-nitroguanidine derivative; organochlorine compound; oxadiazane | antifeedant; carcinogenic agent; environmental contaminant; neonicotinoid insectide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-hydroxymethylmidazolam | | aromatic primary alcohol; imidazobenzodiazepine; monofluorobenzenes; organochlorine compound | drug metabolite; human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-chloromethylglutathione | | organochlorine compound; S-substituted glutathione | alkylating agent; bacterial xenobiotic metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
exp3174 | | biphenylyltetrazole; imidazoles; organochlorine compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
florfenicol | | organochlorine compound; organofluorine compound; secondary alcohol; secondary carboxamide; sulfone | antimicrobial agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monochlorobimane | | organochlorine compound; pyrazolopyrazole | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Prothioconazole-desthio | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saclofen | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piperaquine | | aminoquinoline; N-arylpiperazine; organochlorine compound | antimalarial | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mk 0663 | | bipyridines; organochlorine compound; sulfone | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norketamine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dichloro-1,2,3,4-tetrahydroisoquinoline | | isoquinolines; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxymidazolam | | imidazobenzodiazepine; monofluorobenzenes; organic hydroxy compound; organochlorine compound | drug metabolite; human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cki 7 | | isoquinolines; organochlorine compound; primary amino compound; sulfonamide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-bromo-3-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octene | | monoterpenoid; organobromine compound; organochlorine compound | algal metabolite; antineoplastic agent; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrolomycin a | | antibiotic antifungal agent; C-nitro compound; organochlorine compound; pyrroles | antibacterial agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sk&f 83959 | | benzazepine; catechols; organochlorine compound; tertiary amino compound | dopamine agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-hydroxymethylmidazolam glucuronide | | beta-D-glucosiduronic acid; imidazobenzodiazepine; monofluorobenzenes; monosaccharide derivative; organochlorine compound | drug metabolite; human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cox 189 | | amino acid; monocarboxylic acid; organochlorine compound; organofluorine compound; secondary amino compound | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pannarin | | aldehyde; aromatic ether; depsidones; organic heterotricyclic compound; organochlorine compound; phenols | antimicrobial agent; antineoplastic agent; apoptosis inducer; lichen metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,6-dehydronorketamine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-chloro-3,5-diaminopyrazine-3-carboxamide | | organochlorine compound; pyrazines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quizalofop | | aromatic ether; monocarboxylic acid; organochlorine compound; quinoxaline derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloroorienticin b | | cyclic ether; glycopeptide; heterodetic cyclic peptide; monosaccharide derivative; organochlorine compound; polyphenol | antimicrobial agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lapatinib | | furans; organochlorine compound; organofluorine compound; quinazolines | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cimicoxib | | aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | | chloroindole; organochlorine compound; sulfonamide | antineoplastic agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc-89199 | | carbamate ester; organochlorine compound; steroid phosphate | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estramustine | | 17beta-hydroxy steroid; carbamate ester; organochlorine compound | alkylating agent; antineoplastic agent; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acivicin | | isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound | antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-(chloroacetylcarbamoyl)fumagillol | | carbamate ester; organochlorine compound; semisynthetic derivative; sesquiterpenoid; spiro-epoxide | angiogenesis inhibitor; antineoplastic agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; methionine aminopeptidase 2 inhibitor; retinoic acid receptor alpha antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
griseofulvin | | 1-benzofurans; antibiotic antifungal drug; benzofuran antifungal drug; organochlorine compound; oxaspiro compound | antibacterial agent; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mometasone furoate | | 11beta-hydroxy steroid; 2-furoate ester; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; organochlorine compound; steroid ester | anti-allergic agent; anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ochratoxin a | | isochromanes; monocarboxylic acid amide; N-acyl-L-phenylalanine; organochlorine compound; phenylalanine derivative | Aspergillus metabolite; calcium channel blocker; carcinogenic agent; mycotoxin; nephrotoxin; Penicillium metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorpromazine n-oxide | | organochlorine compound; phenothiazines; tertiary amine oxide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
loteprednol etabonate | | 11beta-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; etabonate ester; organochlorine compound; steroid acid ester; steroid ester | anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
melphalan | | L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromochloroacetic acid | | 2-bromocarboxylic acid; monocarboxylic acid; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tolfenamic acid | | aminobenzoic acid; organochlorine compound; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; EC 2.7.1.33 (pantothenate kinase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,4-dichloro-2-butene | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-chlorophenyl)-1-cyclohexyl-3-(4-morpholinyl)-1-propanol | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(3-chlorophenyl)-(3-oxo-5-propyl-1,2-dihydropyrazol-4-yl)methyl]propanedinitrile | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-piperidinecarboxylic acid (5-chloro-8-quinolinyl) ester | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
transfluthrin | | carboxylic ester; cyclopropanes; organochlorine compound; organofluorine compound | pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tram 34 | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-chlorophenyl)hydrazine-1-carbothioamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-pyridinecarboxylic acid (5-chloro-8-quinolinyl) ester | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
CHIC-35 | | aromatic compound; organic heterotricyclic compound; organochlorine compound; primary carboxamide | EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dieldrin | | epoxide; organochlorine compound; organochlorine insecticide | carcinogenic agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-chlorophenyl)-5-methyl-N-(5-propan-2-yl-1,3,4-thiadiazol-2-yl)-4-isoxazolecarboxamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-(4-chloro-2-methylphenyl)-5-dithiazolimine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(7-chloro-4-quinolinyl)amino]-3-(2,4-dichlorophenyl)thiourea | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-[3-[(2-chlorophenyl)methyl]-2-thiazolylidene]acetamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)guanidine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-6-(methylthio)-4-oxo-2,3-dihydro-1,3-thiazine-5-carbonitrile | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-chlorophenethyl)-N'-(4-chlorophenyl)urea | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | | organochlorine compound; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-7-[3-pyridinyl-(2-pyridinylamino)methyl]-8-quinolinol | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cb 7969312 | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
toremifene | | aromatic ether; organochlorine compound; tertiary amine | antineoplastic agent; bone density conservation agent; estrogen antagonist; estrogen receptor modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ospemifene | | aromatic ether; organochlorine compound; primary alcohol | anti-inflammatory agent; antineoplastic agent; estrogen receptor modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dasatinib | | 1,3-thiazoles; aminopyrimidine; monocarboxylic acid amide; N-(2-hydroxyethyl)piperazine; N-arylpiperazine; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(4-chlorophenyl)methyl]-3-(1-ethyl-5-methyl-4-pyrazolyl)-4,5-dihydroisoxazole-5-carboxamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-butyl-3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-1H-1,2,4-triazole-5-thione | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinoxyfen | | aromatic ether; monofluorobenzenes; organochlorine compound; quinolines | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-7-[1-piperidinyl(2-pyridinyl)methyl]-8-quinolinol | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-7-[(4-ethyl-1-piperazinyl)-(3-pyridinyl)methyl]-8-quinolinol | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML162 | | monochlorobenzenes; monomethoxybenzene; organochlorine compound; secondary carboxamide; tertiary carboxamide; thiophenes | EC 1.11.1.9 (glutathione peroxidase) inhibitor; ferroptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epi 001 | | diether; organochlorine compound | androgen antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(3-chlorophenyl)methylthio]-N-cyclopentylpropanamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[3-(2-chloro-6-methoxy-3-quinolinyl)-5-(2-furanyl)-3,4-dihydropyrazol-2-yl]-5-oxopentanoic acid | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[3-(2-chloro-6-ethoxy-3-quinolinyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-thiophen-2-ylmethanone | | organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-(1,3,4-thiadiazol-2-yl)-5-dithiazolimine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-(2-oxiranyl)methanone | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodronic acid | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ex 527 | | carbazoles; monocarboxylic acid amide; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 60-0175 | | indoles; organochlorine compound; organofluorine compound; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maytansine | | alpha-amino acid ester; carbamate ester; epoxide; maytansinoid; organic heterotetracyclic compound; organochlorine compound | antimicrobial agent; antimitotic; antineoplastic agent; plant metabolite; tubulin modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyhalothrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arachidonyl-2-chloroethylamide | | fatty amide; organochlorine compound; secondary carboxamide; synthetic cannabinoid | CB1 receptor agonist; CB2 receptor agonist; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nostocarboline | | alkaloid; beta-carbolines; organic cation; organochlorine compound | antimalarial; EC 3.1.1.8 (cholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
su 11652 | | olefinic compound; organochlorine compound; oxindoles; pyrrolecarboxamide; tertiary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorferron | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-6-chloropurine | | 2-aminopurines; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodinafop | | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; phenoxy herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salubrinal | | aminal; organochlorine compound; quinolines; secondary carboxamide; thioureas | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picloxydine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ma-1 | | carboxamidine; organochlorine compound; pyrimidone; pyrrolidines | antineoplastic agent; EC 2.4.2.4 (thymidine phosphorylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bifenthrin | | carboxylic ester; cyclopropanecarboxylate ester; cyclopropanes; organochlorine compound; organofluorine compound | pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chaetoviridin a | | azaphilone; beta-hydroxy ketone; enone; gamma-lactone; organic heterotricyclic compound; organochlorine compound; secondary alcohol | antifungal agent; Chaetomium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
su 5614 | | organochlorine compound; oxindoles; pyrroles | vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay 12-9566 | | biphenyls; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[3-(3-chlorophenyl)-5-isoxazolyl]-1-hydroxy-4H-1,2,4-benzotriazin-3-one | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc 716970 | | aromatic amine; aromatic ether; indolecarboxamide; organochlorine compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lonafarnib | | benzocycloheptapyridine; heteroarylpiperidine; N-acylpiperidine; organobromine compound; organochlorine compound; ureas | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cangrelor | | adenosine 5'-phosphate; aryl sulfide; nucleoside triphosphate analogue; organochlorine compound; organofluorine compound; secondary amino compound | P2Y12 receptor antagonist; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyazofamid | | imidazole fungicide; imidazoles; nitrile; organochlorine compound; sulfamides; sulfonamide fungicide | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
avanafil | | aromatic amide; monocarboxylic acid amide; organochlorine compound; prolinols; pyrimidines | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rivaroxaban | | aromatic amide; lactam; monocarboxylic acid amide; morpholines; organochlorine compound; oxazolidinone; thiophenes | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
estin | | 1-benzofurans; ether; methyl ester; organochlorine compound; oxaspiro compound; phenols | Aspergillus metabolite; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pitolisant | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dysidenin | | 1,3-thiazoles; organochlorine compound; secondary carboxamide; tertiary carboxamide | animal metabolite; marine metabolite; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-chlorotryptophan | | L-alpha-amino acid zwitterion; L-tryptophan derivative; non-proteinogenic L-alpha-amino acid; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tolfenpyrad | | aromatic amide; aromatic ether; organochlorine compound; pyrazole insecticide | agrochemical; antifungal agent; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saracatinib | | aromatic ether; benzodioxoles; diether; N-methylpiperazine; organochlorine compound; oxanes; quinazolines; secondary amino compound | anticoronaviral agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marizomib | | beta-lactone; gamma-lactam; organic heterobicyclic compound; organochlorine compound; salinosporamide | antineoplastic agent; proteasome inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyantraniliprole | | nitrile; organobromine compound; organochlorine compound; pyrazole insecticide; pyridines; secondary carboxamide | ryanodine receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lorcaserin | | benzazepine; organochlorine compound | anti-obesity agent; appetite depressant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-chlorophenyl)methyl]-2-(4-ethyl-1-oxo-2-pyrrolo[1,2-d][1,2,4]triazinyl)acetamide | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
complestatin | | cyclic ether; heterodetic cyclic peptide; indoles; organic heterobicyclic compound; organochlorine compound; peptide antibiotic; polyphenol | anti-HIV-1 agent; antimicrobial agent; HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neuroprotectin a | | cyclic ether; heterodetic cyclic peptide; indoles; organochlorine compound; polyphenol | HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cnf 2024 | | 2-aminopurines; aromatic ether; organochlorine compound; pyridines | antineoplastic agent; Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-epichaetoviridin A | | azaphilone; beta-hydroxy ketone; enone; gamma-lactone; organic heterotricyclic compound; organochlorine compound; secondary alcohol | Chaetomium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
plx 4720 | | aromatic ketone; difluorobenzene; organochlorine compound; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(3-chlorophenyl)phenyl]-1-(3-isoxazolylmethyl)-4-piperidinecarboxamide | | biphenyls; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(3-chlorophenyl)phenyl]-1-(3-oxolanylmethyl)-4-piperidinecarboxamide | | biphenyls; organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marinopyrrole a | | aromatic ketone; organochlorine compound; phenols; pyrroles | antibacterial agent; antimicrobial agent; antineoplastic agent; bacterial metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
suvorexant | | 1,3-benzoxazoles; aromatic amide; diazepine; organochlorine compound; triazoles | central nervous system depressant; orexin receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chaetoviridin E | | azaphilone; enone; gamma-lactone; organic heterotricyclic compound; organochlorine compound | Chaetomium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pexidartinib | | aminopyridine; organochlorine compound; organofluorine compound; pyrrolopyridine; secondary amino compound | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloro-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-dithiazolimine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiopental sodium | | organochlorine compound; piperazines; pyrimidines | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
jq1 compound | | carboxylic ester; organochlorine compound; tert-butyl ester; thienotriazolodiazepine | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; bromodomain-containing protein 4 inhibitor; cardioprotective agent; ferroptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide | | aromatic amide; bridged compound; olefinic compound; organochlorine compound; organofluorine compound; pyrazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lornoxicam | | heteroaryl hydroxy compound; monocarboxylic acid amide; organochlorine compound; pyridines; thienothiazine | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
AZD3463 | | aminopiperidine; aminopyrimidine; indoles; monomethoxybenzene; organochlorine compound; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ceritinib | | aminopyrimidine; aromatic ether; organochlorine compound; piperidines; secondary amino compound; sulfone | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
HG-10-102-01 | | aminopyrimidine; aromatic ether; monocarboxylic acid amide; morpholines; organochlorine compound; secondary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
opt 80 | | carboxylic ester; glycoside; macrolide antibiotic; organochlorine compound; phenols | antibacterial drug; bacterial metabolite; EC 2.7.7.6 (RNA polymerase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acarbose | | chondramide; indoles; organochlorine compound; phenols | antineoplastic agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clothianidin | | 1,3-thiazoles; 2-nitroguanidine derivative; clothianidin; organochlorine compound | environmental contaminant; neonicotinoid insectide; nicotinic acetylcholine receptor agonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
THZ531 | | aminopyrimidine; enamide; indoles; N-acylpiperidine; organochlorine compound; secondary amino compound; secondary carboxamide | antineoplastic agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clozapine | | benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound | adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norclozapine | | dibenzodiazepine; organochlorine compound; piperazines | delta-opioid receptor agonist; metabolite; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[1-[(2-chlorophenyl)methyl]-2,5-dimethyl-3-pyrrolyl]-N-(1-methoxypropan-2-yl)-6H-1,3,4-thiadiazin-2-amine | | organochlorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-((4-chlorophenyl)thio)cyclic-3',5'-gmp | | 3',5'-cyclic purine nucleotide; aryl sulfide; organochlorine compound; ribonucleotide | protein kinase agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
XL413 | | benzofuropyrimidine; organochlorine compound; pyrrolidines | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clothianidin | | 1,3-thiazoles; 2-nitroguanidine derivative; clothianidin; organochlorine compound | environmental contaminant; neonicotinoid insectide; nicotinic acetylcholine receptor agonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
Abdominal Epilepsy | 0 | | 2008 | 2022 | 9.5 | low | 3 | 0 | 0 | 2 | 2 | 2 |
Abdominal Migraine | 0 | | 2009 | 2009 | 15.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Absence Seizure | 0 | | 2008 | 2012 | 14.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
Absence Seizure Disorder | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Absence Status | 0 | | 2008 | 2014 | 12.8 | low | 0 | 0 | 0 | 2 | 3 | 0 |
Acute Brain Injuries | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Adenoma Sebaceum | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Aging | 0 | | 2008 | 2008 | 16.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Alcohol Abuse | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Alcohol Drinking | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Alcoholism | 1 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Asymmetric Diabetic Proximal Motor Neuropathy | 0 | | 2014 | 2014 | 10.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Audiogenic Epilepsy | 0 | | 2007 | 2008 | 16.5 | low | 1 | 0 | 0 | 2 | 0 | 0 |
Aura | 0 | | 2007 | 2022 | 13.6 | low | 0 | 0 | 0 | 4 | 0 | 1 |
Benign Essential Tremor | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Benign Psychomotor Epilepsy, Childhood | 0 | | 2014 | 2015 | 9.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Body Weight | 0 | | 2008 | 2008 | 16.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Brain Edema | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Brain Injuries | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Brain Swelling | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Cirrhosis, Liver | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Cognition Disorders | 0 | | 2011 | 2011 | 13.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Complex Partial Epilepsy | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Concussive Convulsion | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Convulsive Generalized Seizure Disorder | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Craniocerebral Injuries | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Craniocerebral Trauma | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Cryptogenic Infantile Spasms | 0 | | 2011 | 2022 | 7.5 | low | 0 | 0 | 0 | 0 | 1 | 1 |
Deficiency, Magnesium | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Depression | 0 | | 2007 | 2007 | 17.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Diabetic Neuropathies | 1 | | 2014 | 2014 | 10.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Disease Models, Animal | 0 | | 2007 | 2015 | 13.4 | low | 0 | 0 | 0 | 5 | 5 | 0 |
Dizziness | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Dizzyness | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Drug Refractory Epilepsy | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Encephalopathy, Toxic | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Epilepsies, Partial | 0 | | 2008 | 2022 | 9.5 | low | 3 | 0 | 0 | 2 | 2 | 2 |
Epilepsy | 1 | | 2007 | 2022 | 13.6 | low | 0 | 0 | 0 | 4 | 0 | 1 |
Epilepsy, Absence | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Epilepsy, Complex Partial | 1 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Epilepsy, Reflex | 0 | | 2007 | 2008 | 16.5 | low | 1 | 0 | 0 | 2 | 0 | 0 |
Epilepsy, Temporal Lobe | 0 | | 2014 | 2015 | 9.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Essential Tremor | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Lennox Gastaut Syndrome | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Lennox-Gastaut Syndrome | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Liver Cirrhosis | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Magnesium Deficiency | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Migraine Disorders | 1 | | 2009 | 2009 | 15.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
Muscle Spasm | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Neuralgia, Postherpetic | 0 | | 2014 | 2014 | 10.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Postherpetic Neuralgia | 0 | | 2014 | 2014 | 10.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
Pregnancy | 0 | | 2009 | 2011 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
Seizures | 1 | | 2008 | 2012 | 14.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
Sensitivity and Specificity | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Spasm | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Spasms, Infantile | 0 | | 2011 | 2022 | 7.5 | low | 0 | 0 | 0 | 0 | 1 | 1 |
Status Epilepticus | 0 | | 2008 | 2014 | 12.8 | low | 0 | 0 | 0 | 2 | 3 | 0 |
Tuberous Sclerosis | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Current and future pharmacotherapy options for drug-resistant epilepsy.Expert opinion on pharmacotherapy, , Volume: 23, Issue:18, 2022
Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons.Epilepsia, , Volume: 49, Issue:10, 2008
A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.Epilepsia, , Volume: 49, Issue:10, 2008
Carisbamate, a new carbamate for the treatment of epilepsy.IDrugs : the investigational drugs journal, , Volume: 10, Issue:10, 2007
Carisbamate (RWJ-333369).Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, , Volume: 4, Issue:1, 2007
Current and future pharmacotherapy options for drug-resistant epilepsy.Expert opinion on pharmacotherapy, , Volume: 23, Issue:18, 2022
Carisbamate add-on therapy for drug-resistant focal epilepsy.The Cochrane database of systematic reviews, , 12-06, Volume: 12, 2021
On-demand pulsatile intracerebral delivery of carisbamate with closed-loop direct neurostimulation therapy in an electrically induced self-sustained focal-onset epilepsy rat model.Journal of neurosurgery, , Volume: 122, Issue:6, 2015
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures.Epilepsia, , Volume: 52, Issue:4, 2011
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials.Epilepsia, , Volume: 51, Issue:3, 2010
Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.Neurology, , Nov-11, Volume: 71, Issue:20, 2008
Neuroprotective agents and modulation of temporal lobe epilepsy.Frontiers in bioscience (Elite edition), , 01-01, Volume: 7, Issue:1, 2015
Attention and executive functions in a rat model of chronic epilepsy.Epilepsia, , Volume: 55, Issue:5, 2014
Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy.Neuropharmacology, , Volume: 61, Issue:1-2
Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms.Epilepsia, , Volume: 52, Issue:9, 2011
Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons.Epilepsy research, , Volume: 83, Issue:1, 2009
Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.Journal of medicinal chemistry, , Mar-22, Volume: 55, Issue:6, 2012
The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.Epilepsy research, , Volume: 79, Issue:2-3, 2008
A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.Epilepsia, , Volume: 49, Issue:10, 2008
Attention and executive functions in a rat model of chronic epilepsy.Epilepsia, , Volume: 55, Issue:5, 2014
A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus.Epilepsia, , Volume: 54, Issue:7, 2013
Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.Journal of medicinal chemistry, , Mar-22, Volume: 55, Issue:6, 2012
What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate.Epilepsia, , Volume: 50 Suppl 12, 2009
The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.Epilepsy research, , Volume: 79, Issue:2-3, 2008
Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.Neurotoxicology and teratology, , Volume: 56
Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.Epilepsia, , Volume: 49, Issue:3, 2008
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.Epilepsy research, , Volume: 74, Issue:2-3, 2007
Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.Epilepsia, , Volume: 49, Issue:3, 2008
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.Epilepsy research, , Volume: 74, Issue:2-3, 2007
On-demand pulsatile intracerebral delivery of carisbamate with closed-loop direct neurostimulation therapy in an electrically induced self-sustained focal-onset epilepsy rat model.Journal of neurosurgery, , Volume: 122, Issue:6, 2015
Attention and executive functions in a rat model of chronic epilepsy.Epilepsia, , Volume: 55, Issue:5, 2014
A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus.Epilepsia, , Volume: 54, Issue:7, 2013
Novel medication targets for the treatment of alcoholism: preclinical studies.Recent patents on CNS drug discovery, , Volume: 7, Issue:2, 2012
Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms.Epilepsia, , Volume: 52, Issue:9, 2011
Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats.Alcoholism, clinical and experimental research, , Volume: 33, Issue:8, 2009
What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate.Epilepsia, , Volume: 50 Suppl 12, 2009
A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.Epilepsia, , Volume: 49, Issue:10, 2008
Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.Epilepsia, , Volume: 49, Issue:3, 2008
Carisbamate, a new carbamate for the treatment of epilepsy.IDrugs : the investigational drugs journal, , Volume: 10, Issue:10, 2007
Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy.Neuropharmacology, , Volume: 61, Issue:1-2
Current and future pharmacotherapy options for drug-resistant epilepsy.Expert opinion on pharmacotherapy, , Volume: 23, Issue:18, 2022
A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.Epilepsia, , Volume: 49, Issue:10, 2008
Carisbamate prevents the development and expression of spontaneous recurrent epileptiform discharges and is neuroprotective in cultured hippocampal neurons.Epilepsia, , Volume: 49, Issue:10, 2008
Carisbamate, a new carbamate for the treatment of epilepsy.IDrugs : the investigational drugs journal, , Volume: 10, Issue:10, 2007
Carisbamate (RWJ-333369).Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, , Volume: 4, Issue:1, 2007
Current and future pharmacotherapy options for drug-resistant epilepsy.Expert opinion on pharmacotherapy, , Volume: 23, Issue:18, 2022
Carisbamate add-on therapy for drug-resistant focal epilepsy.The Cochrane database of systematic reviews, , 12-06, Volume: 12, 2021
On-demand pulsatile intracerebral delivery of carisbamate with closed-loop direct neurostimulation therapy in an electrically induced self-sustained focal-onset epilepsy rat model.Journal of neurosurgery, , Volume: 122, Issue:6, 2015
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures.Epilepsia, , Volume: 52, Issue:4, 2011
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials.Epilepsia, , Volume: 51, Issue:3, 2010
Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.Neurology, , Nov-11, Volume: 71, Issue:20, 2008
Neuroprotective agents and modulation of temporal lobe epilepsy.Frontiers in bioscience (Elite edition), , 01-01, Volume: 7, Issue:1, 2015
Attention and executive functions in a rat model of chronic epilepsy.Epilepsia, , Volume: 55, Issue:5, 2014
Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy.Neuropharmacology, , Volume: 61, Issue:1-2
Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.Journal of medicinal chemistry, , Mar-22, Volume: 55, Issue:6, 2012
A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy.Epilepsia, , Volume: 49, Issue:10, 2008
The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.Epilepsy research, , Volume: 79, Issue:2-3, 2008
Attention and executive functions in a rat model of chronic epilepsy.Epilepsia, , Volume: 55, Issue:5, 2014
A comprehensive behavioral evaluation in the lithium-pilocarpine model in rats: effects of carisbamate administration during status epilepticus.Epilepsia, , Volume: 54, Issue:7, 2013
Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.Journal of medicinal chemistry, , Mar-22, Volume: 55, Issue:6, 2012
What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate.Epilepsia, , Volume: 50 Suppl 12, 2009
The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons.Epilepsy research, , Volume: 79, Issue:2-3, 2008
Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.Neurotoxicology and teratology, , Volume: 56
Safety/Toxicity (3)
Article | Year |
Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials. Pain practice : the official journal of World Institute of Pain, , Volume: 14, Issue:4 | 2014 |
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures. Epilepsia, , Volume: 52, Issue:4 | 2011 |
Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy research, , Volume: 79, Issue:1 | 2008 |
Long-term Use (1)
Pharmacokinetics (4)
Article | Year |
Effect of carisbamate on the pharmacokinetics and pharmacodynamics of warfarin in healthy participants. Journal of clinical pharmacology, , Volume: 52, Issue:9 | 2012 |
Effect of mild and moderate hepatic impairment on the pharmacokinetics and safety of carisbamate. Journal of clinical pharmacology, , Volume: 52, Issue:5 | 2012 |
Pharmacokinetics of carisbamate (RWJ-333369) in healthy Japanese and Western subjects. Epilepsia, , Volume: 50, Issue:8 | 2009 |
Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy research, , Volume: 79, Issue:1 | 2008 |
Dosage (7)
Article | Year |
Cognitive effects of carisbamate in randomized, placebo-controlled, healthy-volunteer, multidose studies. Epilepsy & behavior : E&B, , Volume: 22, Issue:2 | 2011 |
Pharmacokinetics of carisbamate (RWJ-333369) in healthy Japanese and Western subjects. Epilepsia, , Volume: 50, Issue:8 | 2009 |
Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial. Headache, , Volume: 49, Issue:2 | 2009 |
Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly. Epilepsy research, , Volume: 79, Issue:1 | 2008 |
An interaction study between the new antiepileptic and CNS drug carisbamate (RWJ-333369) and lamotrigine and valproic acid. Epilepsia, , Volume: 48, Issue:7 | 2007 |
Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Drug metabolism and disposition: the biological fate of chemicals, , Volume: 35, Issue:4 | 2007 |
The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans. Drug metabolism and disposition: the biological fate of chemicals, , Volume: 35, Issue:4 | 2007 |